Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
A Bergamasco, N Hartmann, L Wallace… - Clinical …, 2019 - Taylor & Francis
Background: Interstitial lung disease (ILD) is one of the leading causes of mortality in
patients with systemic sclerosis (SSc). To further understand this patient population, we …
patients with systemic sclerosis (SSc). To further understand this patient population, we …
Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease.
A Bergamasco, N Hartmann, L Wallace… - Clinical …, 2019 - go.gale.com
Background: Interstitial lung disease (ILD) is one of the leading causes of mortality in
patients with systemic sclerosis (SSc). To further understand this patient population, we …
patients with systemic sclerosis (SSc). To further understand this patient population, we …
[引用][C] Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
A Bergamasco, N Hartmann, L Wallace… - Clinical Epidemiology, 2019 - cir.nii.ac.jp
<p>Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung
disease</p> | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
disease</p> | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease.
A Bergamasco, N Hartmann, L Wallace… - Clinical …, 2019 - europepmc.org
Background: Interstitial lung disease (ILD) is one of the leading causes of mortality in
patients with systemic sclerosis (SSc). To further understand this patient population, we …
patients with systemic sclerosis (SSc). To further understand this patient population, we …
[HTML][HTML] Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
A Bergamasco, N Hartmann, L Wallace… - Clinical …, 2019 - ncbi.nlm.nih.gov
Background: Interstitial lung disease (ILD) is one of the leading causes of mortality in
patients with systemic sclerosis (SSc). To further understand this patient population, we …
patients with systemic sclerosis (SSc). To further understand this patient population, we …
Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
A Bergamasco, N Hartmann, L Wallace… - Clinical …, 2019 - search.proquest.com
Background: Interstitial lung disease (ILD) is one of the leading causes of mortality in
patients with systemic sclerosis (SSc). To further understand this patient population, we …
patients with systemic sclerosis (SSc). To further understand this patient population, we …
Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
A Bergamasco, N Hartmann… - Clinical …, 2019 - pubmed.ncbi.nlm.nih.gov
Background: Interstitial lung disease (ILD) is one of the leading causes of mortality in
patients with systemic sclerosis (SSc). To further understand this patient population, we …
patients with systemic sclerosis (SSc). To further understand this patient population, we …
[PDF][PDF] Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
A Bergamasco, N Hartmann… - Clinical …, 2019 - pdfs.semanticscholar.org
Background: Interstitial lung disease (ILD) is one of the leading causes of mortality in
patients with systemic sclerosis (SSc). To further understand this patient population, we …
patients with systemic sclerosis (SSc). To further understand this patient population, we …
Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
A Bergamasco, N Hartmann, L Wallace… - Clinical …, 2019 - dovepress.com
Background: Interstitial lung disease (ILD) is one of the leading causes of mortality in
patients with systemic sclerosis (SSc). To further understand this patient population, we …
patients with systemic sclerosis (SSc). To further understand this patient population, we …
Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
A Bergamasco, N Hartmann, L Wallace… - Clinical …, 2019 - dovepress.com
Background: Interstitial lung disease (ILD) is one of the leading causes of mortality in
patients with systemic sclerosis (SSc). To further understand this patient population, we …
patients with systemic sclerosis (SSc). To further understand this patient population, we …